Polymer‐Coated Manganese Dioxide Nanoparticles for Foliar Mn Delivery: Mechanisms of Uptake and Metabolic Responses in Mn Deficient Barley
Researchers demonstrated that ~25 nm polyacrylic acid‑coated MnO₂ nanoparticles can rapidly penetrate barley leaves through stomata when applied as a foliar spray. Within two hours the particles dissolve, releasing Mn²⁺ that restores photosynthetic efficiency in Mn‑deficient plants without causing phytotoxicity, even at concentrations up to 4 g L⁻¹. Although ionic Mn showed about 90 % uptake efficiency versus ~11 % for the nanoparticles, the nano‑form delivered sufficient Mn to the vascular bundles and achieved a measurable basipetal translocation of ~1.9 % after four days. The study provides mechanistic insight for designing nano‑carriers to overcome foliar delivery barriers for micronutrient deficiencies.
Hydrophobic Drug-Loaded pRNA Nanoparticles Target Tumors Safely
Researchers have engineered branched four‑way junction (4WJ) RNA nanoparticles that can conjugate up to 24 hydrophobic chemotherapeutic molecules, including camptothecin and paclitaxel. The RNA platform boosts paclitaxel’s water solubility by roughly 32,000‑fold and uses click‑chemistry ester linkers that cleave in...
Engineered Nanofiber‐Based Nerve Guidance Conduit Facilitates the Restoration of Peripheral Nerve Injury Through Enhanced Vascularization
Researchers engineered a nerve guidance conduit (NGC) by coating electrospun polycaprolactone (PCL) nanofibers with endothelial cell‑derived matrix (ECd). The ECd@PCL scaffold provides oriented physical cues and bioactive signals that boost axonal extension in PC12 cells and improve intercellular communication in...
Assessing Performance Management in Malawi’s Primary Healthcare
Malawi’s Ministry of Health launched a nationwide performance‑management review for primary‑care facilities, integrating real‑time data dashboards and quarterly scorecards. The pilot, covering 150 clinics across three districts, showed a 12% increase in routine immunisation coverage and a 9% reduction in...
HHS Is Making an AI Tool to Create Hypotheses About Vaccine Injury Claims
The U.S. Department of Health and Human Services is creating a generative‑AI tool to scan the Vaccine Adverse Event Reporting System (VAERS) and automatically generate hypotheses about potential vaccine injuries. The system, listed in HHS’s 2025 AI inventory, builds on...
Fears US Drug Pricing Deal Will Weigh Heavy on the NHS
UK Science Minister Sir Patrick Vallance confirmed that the £1 billion three‑year drug pricing deal with the United States will be funded from the Department of Health and Social Care budget, not the Treasury. The agreement keeps US tariffs on UK‑origin...
Thomas Farrell
NanoSyrinx, a synthetic‑biology firm developing nanosyringe platforms for intracellular delivery, announced Thomas J. Farrell as its new Chief Executive Officer and Director, succeeding founder Joe Healey. Farrell brings more than 25 years of biotherapeutics leadership, having founded two NASDAQ‑listed companies...
How a Heart Medication Could Unlock a New Targeted Approach in Lymphoma
Researchers at VCU Massey Cancer Center identified dronedarone, an FDA‑approved heart medication, as a selective inhibitor of the deubiquitinase USP11, targeting its non‑catalytic UBL domain. The compound, named RBF4, demonstrated potent activity against MYC‑driven diffuse large B‑cell lymphoma in preclinical...
Induced-Fit Growth of Ga Semiconductors for Neuromorphic Devices
Researchers introduced an “induced fit” growth technique that produces gallium‑based semiconductor thin films capable of atomic‑scale adaptation to substrates. The resulting films exhibit defect‑free crystal structures, high electron mobility, and robust performance under mechanical deformation, enabling flexible neuromorphic and optoelectronic...
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Rare disease drug development is poised for rapid expansion, with the market projected to reach $400‑600 billion by the early‑to‑mid 2030s. Recent FDA guidances, including the plausible‑mechanism approval pathway, aim to accelerate cell and gene therapy approvals for ultrarare conditions. Executives...
Shaping the Future of Microbial Development: From Gene to GMP
Fujifilm Biotechnologies is hosting a free webinar titled “Shaping the Future of Microbial Development: From Gene to GMP.” The session, led by Steve Loftus, PhD, will showcase proven strategies and emerging technologies that accelerate microbial fermentation, scale‑up, and regulatory readiness....
Minimally Invasive Luciferases for Precise Tumor Tracking
Researchers at the BioInnovate Institute have unveiled a suite of engineered luciferases that emit near‑infrared light, allowing minimally invasive, high‑resolution tumor tracking in live animals. The new enzymes deliver up to three‑fold greater signal intensity than conventional firefly luciferase, while...
Does Waiting Influence Patient Revisit Decisions?
A new BMC Health Services Research study by Liu and Zhao examines how waiting time shapes patients' willingness to return to fever clinics in post‑epidemic China. Using empirical data from multiple clinics, the authors find that both the actual duration...
2021 Sparked a Banner Year for Biotech IPOs. Where Are They Now?
In 2021 a pandemic‑driven gold rush produced 99 biotech IPOs that raised $15.6 billion, dwarfing the combined proceeds of 2023‑24. The surge created a “logical gap,” with many companies going public before their science was mature, leading to bankruptcies, pivots, and...
FDA Seeks Withdrawal of Amgen's Tavneos, Company Says It Won't Pull Drug
The U.S. Food and Drug Administration has formally asked Amgen to withdraw its rare‑disease therapy Tavneos from the market, citing unresolved safety and manufacturing concerns. Amgen’s CEO Bob Bradway publicly rejected the request, stating the company will continue to sell...
How Urban Environments Enabled Spotted Lanternflies to Flourish in the US
The spotted lanternfly, an invasive pest native to Asia, has rapidly expanded across the United States as urban environments provide ideal habitats and dispersal pathways. Cities offer abundant host trees, heat islands, and fragmented green spaces that accelerate breeding cycles...
Mold Exposure Linked to Arthritis in Older Chinese Adults
A new epidemiological study of 5,000 Chinese adults over 60 finds a statistically significant association between chronic indoor mold exposure and increased prevalence of rheumatoid arthritis. Researchers measured mold levels using home inspections and questionnaires, linking higher spore counts to...
Reproduction in Space, an Environment Hostile to Human Biology
A new study in Reproductive Biomedicine Online warns that space’s radiation, microgravity and circadian disruption create a hostile environment for human reproduction. It highlights the absence of industry‑wide standards for managing fertility risks, early pregnancy, and ethical dilemmas as commercial...
Developmental Changes of the White Matter Functional Connectome
Recent comprehensive analyses synthesize decades of neuroimaging work to map how the functional connectome of white matter evolves from childhood through late adulthood. Across longitudinal diffusion MRI and resting‑state BOLD studies, researchers observe a steady rise in inter‑regional synchrony, the...
Sex Differences in the Risk of Autistic-Related Traits in Toddlers Born to Mothers with Perinatal Depression: Evidence From Human Cohort...
Maternal perinatal depression (MPD) was linked to higher autistic‑related trait (ART) scores in toddlers across a Japanese cohort of 23,218 mother‑child pairs. Women with early or mid‑gestational psychological distress or postpartum depression showed 3‑4‑fold increased odds of ART overall, while...
Novel Selective Morpholine Trace Amine-Associated Receptor 1 Partial Agonists Show Promising Preclinical Effects for Neuropsychiatric Disorders and Are Well Tolerated...
Roche researchers have disclosed a new series of selective morpholine‑based trace amine‑associated receptor 1 (TAAR1) partial agonists that demonstrate robust antipsychotic, antidepressant and anti‑addiction activity in preclinical models. The compounds were advanced into a Phase‑1 study in healthy volunteers, where they...
Bidirectional Association Between Immune-Mediated Diseases and Major Depressive Disorder: Evidence From Cohort, Genome-Wide Pleiotropic, and Experimental Studies
A multi‑modal investigation reveals a two‑way relationship between major depressive disorder (MDD) and immune‑mediated diseases. Large cohort analyses show that depression raises the incidence of autoimmune conditions by roughly 20%, while pre‑existing autoimmune diagnoses similarly increase the risk of developing...
Rep. Auchincloss Challenges Legality of Commissioner’s National Priority Voucher Program
Representative Jake Auchincloss, a member of the House Energy and Commerce Committee, sent a formal letter to FDA Commissioner Marty Makary demanding a review of the commissioner’s national priority voucher (CNPV) program. Auchincloss argues the program, which awards expedited review...
Backward Walking Study Reveals Promising New Approach to Enhance Mobility and Reduce Falls in Multiple Sclerosis Patients
The Wayne State University team demonstrated that an eight‑week backward‑walking program significantly improves gait speed and postural control in multiple sclerosis patients. Neuroimaging revealed enhanced white‑matter integrity in the corpus callosum, superior cerebellar peduncle, and corticospinal tract, indicating neuroplastic adaptation....
AI Startup Phylo Nabs $13.5M for Its ‘Integrated Biology Environment’
Phylo Inc., an AI‑driven biology software startup, announced a $13.5 million seed round led by Andreessen Horowitz with participation from Menlo Ventures’ Anthology Fund and other investors. The company’s flagship product, Biomni Lab, acts as an integrated biology environment that links...
Mini-Bladder Model Uncovers Urine’s Role in UTI Recurrence
Researchers have built a micro‑physiological human mini‑bladder that reproduces the bladder’s stretch, urine flow, and urothelial architecture. The platform reveals that urine itself modulates barrier function and immune signaling, influencing how uropathogenic E. coli invade and persist. By tracking bacterial...
Researchers Reveal How Biochar Microzones Shield Crops From Toxic Cadmium Exposure
Researchers have demonstrated that biochar microzones can sequester toxic cadmium, dramatically reducing its uptake by crops. Laboratory experiments revealed that the porous carbon matrix creates localized chemical environments that bind cadmium ions, preventing root absorption. Field trials across contaminated soils...
Study Reveals How Urban Light Pollution Disrupts Nighttime Hormones in Sharks
A University of Miami study provides the first field evidence that artificial nighttime lighting suppresses melatonin in wild nurse sharks, while mobile blacktip sharks remain hormonally unaffected. Researchers measured plasma melatonin in sharks from illuminated Miami coastal waters and linked...
Spending Law a Rebuke to Proposed White House Biomedical Cuts
Congress approved a $48.7 billion budget for the NIH in FY2026, modestly increasing funding by $415 million while rejecting the Trump administration’s $27.9 billion request that would have cut the agency by roughly 40 percent. The appropriations bill also restores pediatric priority review vouchers,...
Exploring Sox Gene Diversity in Brachyuran Crabs
Researchers Chen, Xie and Bao have completed a genome‑wide survey of the Sox transcription factor family in three brachyuran crab species. The analysis uncovered a variable complement of Sox genes, traced their evolutionary diversification, and documented stage‑specific expression patterns from...
Culture: The Key to Sustainable Food Systems
A new study by Nicolette Einbinder in npj Sustainable Agriculture argues that culture is the missing link in achieving sustainable food systems. The research demonstrates how cultural traditions, food sovereignty, and indigenous knowledge directly affect biodiversity, soil health, and consumer...
Phase 2 Trial Assesses C-Abl Inhibitor for Early Parkinson’s
Researchers reported that vodobatinib, a selective c‑Abl inhibitor, met primary endpoints in a phase 2, double‑blind trial for early Parkinson’s disease. Participants receiving the drug showed statistically significant improvements in MDS‑UPDRS scores and reductions in phosphorylated alpha‑synuclein biomarkers. Neuroimaging demonstrated slower...
Resource Competition Shapes the Human Vaginal Microbiome
A new study in PLOS Biology introduces a resource‑based ecological model that explains how competition for glycogen‑derived nutrients shapes the vaginal microbiome. The model, calibrated with clinical samples from the United States and France, shows that Lactobacillus species dominate by...
Fungus Within the Body Linked to Increased Aggressiveness of Melanoma, New Study Reveals
A recent study links the presence of internal fungi, particularly Malassezia species, to heightened aggressiveness in melanoma patients. Analysis of over 200 tumor samples showed that higher fungal loads correlate with increased metastasis risk and reduced survival. Mouse models treated...
Quebec’s Multi-Ancestry Genetic Reference Unveiled
Quebec’s health ministry unveiled a multi‑ancestry genetic reference panel covering over 10,000 volunteers from Indigenous, French‑Canadian, African‑Caribbean, Asian and recent immigrant groups. The high‑coverage whole‑genome data, paired with detailed phenotypes, creates a population‑specific baseline for variant frequencies absent from global...
SCAI Expert Opinion Highlights Advances in Wire-Free Angiography-Derived Physiology for Coronary Assessment
The Society for Cardiovascular Angiography & Interventions (SCAI) released an expert opinion highlighting angiography‑derived physiology (ADP) as a wire‑free alternative for coronary lesion assessment. ADP combines AI‑driven computational fluid dynamics with standard angiograms to generate physiological metrics without pressure wires....
Novo Expects Sales to Fall in 2026, Triggering Selloff
Novo Nordisk announced it expects sales to decline by at least 5% in 2026, marking the first projected contraction in years. The slowdown is driven by adverse pricing dynamics, notably the U.S. government’s new price caps on GLP‑1 therapies. The...
Novo Slides 14% as Early Q4 Results Predict Sales Decline for 2026
Novo Nordisk previewed its early Q4 results, showing a 5% sales decline forecast for 2026 driven by lower U.S. drug prices. The company beat analyst expectations in the quarter, with Ozempic and Wegovy outperforming by 9% and 3% respectively. Shares...
Developing and Validating the Nursing Infection Control Index
The study by Wang, Xin and Lang introduces the Nursing Infection Control Effectiveness Index (NICEI), a validated tool that measures how well nursing practices prevent healthcare‑associated infections. Using a sequential mixed‑methods approach, the researchers gathered qualitative insights from nurses and...
Iain Couzin Honored with the Hector Science Award
Professor Iain Couzin was awarded the 200,000‑euro Hector Science Award on Jan. 30, 2026 in Heidelberg, recognizing his pioneering work on the neural and behavioral rules that drive collective motion in animals. The honor, shared with biochemist Stefanie Dimmeler, underscores Couzin’s leadership...
Breath Sound Spectrum: Healthy Kids Vs. Cough Asthma
Recent BMC Pediatrics research led by Lv, Hu and Liu shows that children with cough variant asthma have distinct breath sound spectra compared with healthy peers. Advanced audio analysis identified specific frequency signatures that could serve as a non‑invasive diagnostic...
'Turning Around the Titanic': How the Incoming PBM Reforms Will Transform CMS
The Centers for Medicare & Medicaid Services (CMS) is set to roll out sweeping pharmacy‑benefit‑manager (PBM) reforms that will impose transparency, rebate‑disclosure, and reporting requirements on the industry. The rulemaking, slated for finalization in early 2025, targets the opaque pricing...
Pfizer’s Early Metsera Data Leaves Analysts Wanting More
Pfizer disclosed early Phase IIb data for its Metsera‑acquired obesity drug PF’3944, showing a 12.3% average weight loss at week 28 in the 3.2‑mg and 4.8‑mg monthly dosing arms. Analysts noted the placebo‑adjusted loss is roughly 12%, trailing Eli Lilly’s Zepbound 16%...
No Fences Needed: GPS Collars Show 'Virtual Fencing' Is Next Frontier of Livestock Grazing
University of Missouri’s Center for Regenerative Agriculture is beta‑testing a virtual fencing system that uses GPS‑enabled collars and a mobile app to guide livestock. Five Missouri producers—four cattle, one sheep—have adopted the technology, reporting easier fence management and real‑time animal...
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline
Merck met its 2025 sales guidance, reporting fourth‑quarter revenue of $16.4 billion, slightly above expectations. The company’s HPV vaccine Gardasil saw a 35% global decline, driven by weak demand in China and Japan. CEO Robert Davis countered modest‑growth criticism by highlighting...
China Startup AccurEdit Raises $75M for Gene Editing Therapies
AccurEdit, a Chinese biotech startup, closed a $75 million Series B round to accelerate its CRISPR‑based gene‑editing therapies. The funding, led by Hillhouse Capital and Sequoia China, will finance IND‑enabling studies and scale GMP manufacturing. Early preclinical data show over 90 percent editing...
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
In the latest Behind the Headlines episode, NVIDIA and Eli Lilly announced a $1 billion, five‑year AI co‑innovation lab aimed at fusing wet‑lab experiments with continuous‑learning computational models. Panelists highlighted AI’s growing role in lowering drug‑development costs and accelerating clinical‑trial timelines, moving...
Warning of Kidney Cell Damage From High Exposure to Nanoplastics
Flinders University researchers have demonstrated that high concentrations of nanoplastics can damage kidney cells, altering shape, survival and regulatory functions. The laboratory study exposed renal cells to polystyrene, PMMA and polyethylene particles of varying sizes, finding toxicity depends on both...
Daiichi Ends Work on an ADC; Layoffs at GSK's R&D Unit
Daiichi Sankyo announced it is terminating development of its antibody‑drug conjugate (ADC) program aimed at solid‑tumor indications, citing strategic reprioritisation and cost considerations. The cancellation eliminates an estimated $200 million of projected R&D spend. Meanwhile, GlaxoSmithKline disclosed a reduction of roughly...
'Sponge City' Construction Fuels Major Gains in Urban Biodiversity, Study Reveals
A new study published in Cell Reports Sustainability shows that China’s Sponge City Program (SCP) has boosted urban plant richness by more than 50 percent in the Wuxi demonstration zone. Between 2020 and 2023, 1,973 green‑infrastructure installations such as rain...
